Sir,
Delayed vitreous haemorrhage is an exceedingly rare complication of cataract surgery; in the paediatric population, it can result in significant visual morbidity. The case presented demonstrates that Lowe syndrome patients can have disorders of primary haemostasis, and may be predisposed to this complication.
Case report
A 4-week-old term male infant presented with absent red reflexes bilaterally. Examination revealed bilateral dense cataracts, with no view to the posterior segment. B-scan ultrasonography was unremarkable.
The patient underwent left lensectomy and anterior vitrectomy. Fundus examination immediately post-operatively revealed a small peripapillary haemorrhage, which remained unchanged at 1 day post-operatively.
Two weeks later, uncomplicated cataract surgery was performed on the right eye. Simultaneous examination under anaesthesia of the left eye revealed corneal haze, hyphaema, and a dense vitreous haemorrhage (VH). There was no retinal detachment (RD) on B-scan. A pars plana vitrectomy (PPV) was planned, but the patient was lost to follow-up. When the PPV was performed 3 weeks later, a funnel RD with significant proliferative vitreoretinopathy was noted. Densiron-fluid exchange was also performed. The patient was again lost to follow-up and returned 3 months later, with a total fibrotic RD (Figure 1). The family declined further surgery, and at last follow-up, the left eye was phthisical.
Genetic testing revealed a c.940-11 G>A splice site mutation in the oculocerebrorenal gene (OCRL-1), confirming the diagnosis of Lowe syndrome. The patient subsequently developed the classic findings of renal tubulopathy, hypotonia, Rickets syndrome, and developmental delay. Testing revealed abnormal platelet function (Table 1).
Comment
Lowe syndrome is an X-linked recessive disorder, associated with mutations in the OCRL-1 gene (locus Xq26).1, 2 Affected males develop bilateral cataracts requiring surgery.3, 4 Delayed VH is an exceedingly rare complication of paediatric cataract surgery.5, 6 There have been isolated reports of intraoperative hyphaema in Lowe syndrome patients undergoing cataract and goniosurgery.7, 8, 9 To our knowledge, this is the first reported case of delayed post-operative VH after routine cataract surgery in a Lowe syndrome patient.
The OCRL gene regulates signalling pathways essential for normal platelet function.10, 11, 12 OCRL mutations have been linked to systemic haemorrhagic events. Routine coagulation testing can be normal, but many patients have increased platelet closure times. The Platelet Function Analyser (PFA-100) test measures platelet adhesion and aggregation.13, 14 It can be elevated in primary haemostatic disorders, as was the case in our Lowe syndrome patient.
Surgeons need to be aware of systemic haemostatic disorders in Lowe syndrome patients undergoing cataract surgery. Routine haematological testing may be within normal limits. More specialised testing may be necessary to identify this increased bleeding risk.
References
Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA et al. The Lowe’s oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 1992; 358: 239–242.
Satre V, Monnier N, Berthoin F, Ayuso C, Joannard A, Jouk PS et al. Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene. Am J Hum Genet 1999; 65: 68–76.
Gaary EA, Rawnsley E, Marin-Padilla JM, Morse CL, Crow HC . In utero detection of fetal cataracts. J Ultrasound Med 1993; 12: 234–236.
McSpadden K, Dolinsky Z, Schroerlucke MS . Report on the Lowe’s Syndrome Comprehensive Survey. The Lowe Syndrome Association: West Lafayette, IN, USA, 1991.
Chen TC, Bhatia LS, Walton DS . Complications of pediatric lensectomy in 193 eyes. Ophthalmic Surg Lasers Imaging 2005; 36: 6–13.
Kuhli-Hattenbach C, Lüchtenberg M, Kohnen T, Hattenbach LO . Risk factors for complications after congenital cataract surgery without intraocular lens implantation in the first 18 months of life. Am J Ophthalmol 2008; 146 (1): 1–7.
Lasne D, Baujat G, Mirault T, Lunardi J, Grelac F, Egot M et al. Bleeding disorders in Lowe syndrome patients: evidence for a link between ORCL mutations and primary hemostasis disorders. Br J Haematol 2010; 150: 685–688.
Spierer A, Desatnik H . Anterior chamber hemorrhage during cataract surgery in Lowe syndrome. Metab Pediatr Syst Ophthalmol (1985) 1998; 21: 19–21.
Curtin VT, Joyce EE, Ballin N . Ocular pathology in the oculo-cerebrorenal syndrome of Lowe. Am J Ophthalmol 1967; 64: 533–543.
Faucherre A, Desbois P, Satre V, Lunardi J, Dorseuil O, Gacon G et al. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. Hum Mol Genet 2003; 12: 2449–2456.
Suchy SF, Nussbaum RL . The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am J Hum Genet 2002; 71: 1420–1427.
Raucher D, Stauffer T, Chen W, Shen K, Guo S, York JD et al. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton- plasma membrane adhesion. Cell 2000; 100: 221–228.
Lasne D, Fiemeyer A, Chatellier G, Chammas C, Baron JF, Aiach M . A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 2000; 84: 794–799.
Karger R, Donner-Banzhoff N, Müller HH, Kretschmer V, Hunink M . Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis. Platelets 2007; 18 (4): 249–260.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mikhail, M., Modabber, M., Koenekoop, R. et al. Delayed vitreous haemorrhage after paediatric cataract surgery in Lowe syndrome. Eye 30, 1272–1273 (2016). https://doi.org/10.1038/eye.2016.100
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2016.100